Search results
Merck, Kelun-Biotech Ink Licensing Pact For Seven Cancer Candidates
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc (NYSE: MRK) and Kelun-Biotech (a holding subsidiary of Sichuan Kelun Pharmaceutical...
Merck (MRK) Inks Deal to Develop Antibodies for Treating Cancer
Zacks via Yahoo Finance· 1 year agoMerck (MRK) partners with Kelun-Biotech to develop seven antibody-drug conjugates targeting cancer...